Cipla drops 5 percent as a result of fears against Goa unit

The Indian multinational biotechnology and pharmaceutical company-Cipla has dropped to 5% in Friday’s session. The dive is attributed to extensive changes by Capital market company-Equirius, which said the unit will have to meet the changes as per the USFDA guidelines. 
News sources of Equirius allege the unit received Form 483 with 12 observations and is compiled within 38 pages.  Furthermore, the Mumbai based capital c....